Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesProspective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function
Supportive Care in Cancer, 06/15/09
Choo R et al. – Study reports that among patients with clinically localized prostate cancer referred for radiotherapy, sexual dysfunction was prevalent; with 35.9% reporting erectile dysfunction (ED) at presentation. Radiotherapy adversely affected all aspects of sexual function.
Methods- Purpose of this study was to:
- assess sexual function among pts with clinically localized PCa referred for radiotherapy and
- prospectively evaluate the effect of radiotherapy on sexual function, using the Brief Sexual Function Inventory (BSFI)
- At baseline, pts were asked to complete a self-administered BSFI
- Pts with normal erection at baseline were asked to complete a follow-up BSFI at 6, 12, and 24 mo postradiotherapy
- 117 eligible pts; mean age: 66 yrs; 42 pts (35.9%) had ED at baseline:
- These pts were older
- More likely on one or more medications affecting potency
- Had lower mean score for all the 5 domains of BSFI and
- Considered sexual activity less important
- 61/75 pts reporting normal erectile function at baseline, completed a f/u BSFI questionnaire:
- 52 underwent radiotherapy with external beam radiotherapy or brachytherapy
- Mean scores for all the BSFI domains declined after radiotherapy
suggesting that radiotherapy adversely affected not only erectile function but also other aspects of sexual function including sexual drive and ejaculation
Today in Erectile Dysfunction...keeping you current
Receive free subspecialty "5-minute updates" via email
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/20/09
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Annals of Internal Medicine, 10/21/09
Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
JAMA, 10/14/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Article Search
Sponsor